Science and Technology Committee

Debate between Philip Hollobone and Norman Lamb

Thursday 6th September 2018 Commons Chamber

[Norman Lamb]

I thank the hon. Gentleman for his helpful contribution and totally agree with him. I will make sure that we specifically send the report to the devolved Administrations, and he highlights the fact that there is now such strong consensus through all the organisations I referred to—Cancer Research UK, the British Heart Foundation and so on—of the relative harm reduction through adopting e-cigarettes as opposed to smoking. Any confusion of that message will result in fewer people giving up smoking and more people in our country dying, and we must stop that.

[Mr Philip Hollobone (Kettering) (Con)]

I was staggered to read in the right hon. Gentleman’s report that NHS England does not have a dedicated person responsible for implementing the Government’s tobacco control plan and failed to provide a representative to the Committee and that there is no one in NHS England in charge of the oversight of e-cigarette policies among NHS mental health trusts. Given that e-cigarettes are, according to NHS England, 95% less harmful and that early morbidity for mental health patients can take 15 to 20 years off their lives, is this not a shocking state of affairs that NHS England must address urgently?

Brexit, Science and Innovation

Debate between Philip Hollobone and Norman Lamb

Thursday 6th September 2018 Commons Chamber

[Norman Lamb (North Norfolk) (LD)]

I beg to move,

That this House takes note of the Science and Technology Committee’s Second Report on Brexit, science and innovation, HC 705, and the Government Response, Fifth Special Report, HC 1008; further takes note of the Science and Technology Committee’s Eighth Report on An immigration system that works for science and innovation, HC 1061; believes that the Government should seek to agree with the EU the far-reaching science and innovation accord proposed by the Prime Minister in her Mansion House speech and in The Future Relationship Between the United Kingdom and the European Union White Paper, Cm 9593; calls for this accord to be negotiated separately from wider EU-UK trade negotiations; and further calls for the science and innovation accord to include details of an immigration system that works for the science and innovation community.

It’s me again, I’m afraid. The motion relates to two recent reports from the Science and Technology Committee, and I again thank the members of the Committee for their work on the inquiries. I also thank the Liaison Committee for recommending to the Backbench Business Committee that the House should have the opportunity to hold this debate today. The House has spent many hours discussing the implications of leaving the European Union for the big political issues, such as trade, regulation and freedom of movement, often in ways that are deeply divisive between those who support remaining in the EU and those who believe we should be leaving, which was the decision in the referendum. Today, however, we have an opportunity to explore the effects of Brexit on something which, at least in theory, is less politically contentious for many but just as important to get right.

No one is rushing to the barricades to demand the end to scientific collaboration, about which we should all be able to agree. I am sure that Members across the House will want to join me in underlining the absolute importance of science and innovation to the economy, but I hope that today will also help to generate some political momentum to make it certain that science does not become a casualty of the Brexit process, particularly given the concerns that no deal could emerge from the negotiations.

[Mr Philip Hollobone (Kettering) (Con)]

I welcome the right hon. Gentleman’s introductory remarks. Despite our views on Brexit, I am sure that we are on the same page. Does he agree that this country has led the world in many scientific discoveries for hundreds of years and that there has been close collaboration on such discoveries across Europe for hundreds of years? Scientific collaboration did not start on 1 January 1973 and will not end on 29 March next year. Can we agree on that?

[Norman Lamb]

I thank the hon. Gentleman. In a sense, these reports are all about seeking to ensure that collaboration does continue beyond March next year, and I of course completely accept that fact about collaboration, not just across Europe, but across the world.

My Committee has produced two reports this year looking at the impact of Brexit on science and innovation. They build on work undertaken by my two predecessor Committee Chairs and their Committees in the 2015 Parliament. One of those Chairs was the hon. Member for South Basildon and East Thurrock (Stephen Metcalfe), who continues to be a member of the Science and Technology Committee. I pay tribute to him for his work and note that he is in his seat for this debate. The first of this year’s two reports, as referenced on the Order Paper, was published in March following a summit with more than 50 representatives of the science and innovation community. We are grateful for the community’s willingness both to respond quickly to our call for evidence and to participate in that event.

The report recognises the current strength of British science on the world stage and the Government’s commitment to science and research through a range of policies. For instance, the Government have made science a key pillar of the industrial strategy, and they have also committed to increase R&D spending further to the OECD average of 2.4% of GDP by 2027.

Those commitments are very welcome, but the shadow of whether the UK will participate in all aspects of EU schemes such as Horizon 2020 and its successor programme after March 2019 looms large. Whatever form of Brexit we end up with, there is a need to make sure that the international standing of UK research is protected, and indeed strengthened, following March next year.

A key recommendation of our report is that the Government should explicitly commit to seeking associated country status for Horizon 2020’s successor programme, now known as Horizon Europe. The UK has received €4.73 billion from Horizon 2020 to date, and Horizon Europe is set to be a huge increase in ambition, and the pot of money available will total €100 billion from 2021 to 2027.

Since our report, the Government’s no deal technical note on Horizon 2020 funding has underlined the importance of such close association. The note confirms that, without a deal that secures associated country status, we will not be eligible to participate in some very important elements of Horizon 2020 during its remaining years, including European Research Council funds. The campaign group Scientists for EU has calculated that we stand to lose around £0.5 billion each year in the event of no deal by not being eligible to access those funds, although it is important to say that presumably we would not be paying in during that period either.

The plans for Horizon Europe set out an enhanced role for third countries—in other words, countries outside the EU—in the new scheme when Horizon 2020 has run its course. The Government have played their part in shaping the programme for Horizon Europe, but the Minister has said that participation is contingent on three things.

First, it is contingent on the programme’s continued focus on excellence. I think we have reassurance, but it would be helpful if the Minister updated us. Secondly, it is contingent on agreeing a suitable participation fee. The Minister has said that he supports participation but “not at any price”. Thirdly, it is contingent on securing a suitable level of influence on the programme.

The last point remains a challenging issue. We are likely to be one of the biggest contributors to the programme if we do participate, but the proposed rules for Horizon Europe prevent third countries from having “decisional powers” over the programme. In financial terms, it appears that we will not be allowed to get more out than we put in, as we have been able to do in the past.

The Minister will need to be able to sell the idea of participation to the Treasury, which on the face of it is made more challenging by there being no voting rights, according to the EU’s current position. On the other hand, formal voting is rarely, if ever, necessary, and there may be other ways in which the UK could have influence over the programme if the EU will not shift on formal voting rights. Either way, the science community takes the view that striking an agreement is vital, as this international funding programme is so important and so highly regarded.

Incidentally, I also urge the EU negotiators to demonstrate some flexibility, because if the UK is to be one of the largest contributors to the programme, it does not seem unreasonable that we should be given decision-making powers as a third country.

Child and Adolescent Mental Health Services

Debate between Philip Hollobone and Norman Lamb

Monday 2nd February 2015 Commons Chamber

[Mr Philip Hollobone (Kettering) (Con)]

Which is the best CAMHS service in the country, why can it do it when others cannot, and what is stopping its best practice from being copied?

[Norman Lamb]

My hon. Friend makes an important point, and there are many excellent mental health services, as the hon. Member for somewhere in Birmingham—[Interruption.]—for Halesowen and Rowley Regis (James Morris), said earlier. If some areas can do things well with the available resources, then other areas can too. It is also true that some areas have chosen to cut funding for children’s mental health, in my view inappropriately.

Oral Answers to Questions

Debate between Philip Hollobone and Norman Lamb

Tuesday 13th January 2015 Commons Chamber

[Norman Lamb]

The Nicholson challenge, which was published in the last year of the Labour Government, recognised that the whole system had to deliver efficiency savings, and I think that everyone understands that. But the answer to all of this is a significant shift of emphasis towards preventing ill health and preventing crises from occurring. Under the better care fund the NHS and the care system are for the first time being properly joined together.

[Mr Philip Hollobone (Kettering) (Con)]

The Northamptonshire clinical commissioning groups and Kettering general hospital are agreed that Kettering’s A and E department is too small and outdated and needs to be replaced with an urgent care hub in line with the NHS five-year forward view. Given that the three local MPs on a cross-party basis refused to treat our local A and E as a political football, will the Minister of State encourage his colleague, the hospitals Minister, to consider that proposal seriously when we come to see him this afternoon?

[Norman Lamb]

I understand that a meeting will take place very soon, and I certainly encourage my hon. Friend the hospitals Minister to ensure that he listens to the case being put by the hon. Gentleman and his colleagues this afternoon.

Care Homes

Debate between Philip Hollobone and Norman Lamb

Thursday 1st May 2014 Commons Chamber

[Norman Lamb]

I am grateful to the hon. Gentleman for raising that point. In a way, he makes the case for why the inspection regime needs to be much more robust and not a tick-box exercise. More effective inspection, with inspectors talking to staff and, crucially, relatives of those in the care home, will provide a much better picture of what is going on there. It is for the CQC as the employer to address any concerns it has about the way in which its staff have conducted themselves, but the new tough inspection regime is being introduced, with 1% of care homes already covered. It will be fully implemented by October this year.

[Mr Philip Hollobone (Kettering) (Con)]

I applaud the Minister for his efforts to change the prosecution regime for residential care home abuse, but is he optimistic that he can get the changes through so that we might see some exemplary prosecutions by the end of this year?

Oral Answers to Questions

Debate between Philip Hollobone and Norman Lamb

Tuesday 16th April 2013 Commons Chamber

[Norman Lamb]

The hon. Lady raises a very important point, and I would be delighted for her to join the meeting rather than my having another one.

[Mr Philip Hollobone (Kettering) (Con)]

T8. Kettering general hospital’s new £30 million foundation wing has a new 16-bed intensive care unit, 28-bed cardiac unit and 32-bed children’s unit, and it opens to patients for the first time this coming Saturday. Will my right hon. Friend the Secretary of State take this opportunity to congratulate all those at Kettering general hospital who have brought this project to fruition?